IDIOPATHIC ARTHRITIS (INCLUDING SJIA, PJIA, OR JPSA)

Clinical trials for IDIOPATHIC ARTHRITIS (INCLUDING SJIA, PJIA, OR JPSA) explained in plain language.

Never miss a new study

Get alerted when new IDIOPATHIC ARTHRITIS (INCLUDING SJIA, PJIA, OR JPSA) trials appear

Sign up with your email to follow new studies for IDIOPATHIC ARTHRITIS (INCLUDING SJIA, PJIA, OR JPSA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Special access program opens for investigational drug for inflammatory diseases

Disease control AVAILABLE

This program provides eligible patients with access to the drug upadacitinib for conditions like Crohn's disease, ulcerative colitis, and atopic dermatitis before it is officially approved in their country. A doctor must determine if the potential benefits for an individual patie…

Matched conditions: IDIOPATHIC ARTHRITIS (INCLUDING SJIA, PJIA, OR JPSA)

Sponsor: AbbVie • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

IDIOPATHIC ARTHRITIS (INCLUDING SJIA, PJIA, OR JPSA)

Get alerted when new IDIOPATHIC ARTHRITIS (INCLUDING SJIA, PJIA, OR JPSA) trials appear

Special access program opens for investigational drug for inflammatory diseases